Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: MAYO CLINIC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2017-09-15 to 2024-06-04
Current total value of award: $364672.04
Description: IGF.OT.IGF PHASE I DOUBLE-BLIND, PLACEBO-CONTROLLED TRAIL OF 0.3MG LINACLOTIDE DELAYED-RELEASE (DR1) TO DEMONSTRATE COLORECTAL BIOACTIVITY IN HEALTHY VOLUNTEERS (MAY2017-09-01)